There is an extremely high risk that severe birth defects will result if pregnancy occurs while taking this drug. In October 2018, sarecycline (Seysara) tablets were FDA-approved for the treatment of non-nodular moderate to severe acne vulgaris. Tazarotene topical (Arazlo, Fabior, Tazorac), ...